These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 21618688)
1. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Dutkowski P; Oberkofler CE; Béchir M; Müllhaupt B; Geier A; Raptis DA; Clavien PA Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688 [TBL] [Abstract][Full Text] [Related]
2. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score. Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152 [TBL] [Abstract][Full Text] [Related]
3. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil. Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144 [TBL] [Abstract][Full Text] [Related]
4. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170 [TBL] [Abstract][Full Text] [Related]
5. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196 [TBL] [Abstract][Full Text] [Related]
6. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy. Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946 [TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Yao FY; Bass NM; Ascher NL; Roberts JP Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253 [TBL] [Abstract][Full Text] [Related]
8. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434 [TBL] [Abstract][Full Text] [Related]
9. LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Bruns H; Hillebrand N; Schneider T; Hinz U; Fischer L; Schmidt J; Goldschmidt AJ; Schemmer P Clin Transplant; 2011; 25(5):E558-65. PubMed ID: 21585550 [TBL] [Abstract][Full Text] [Related]
11. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732 [TBL] [Abstract][Full Text] [Related]
12. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore. Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430 [TBL] [Abstract][Full Text] [Related]
13. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Machicao VI; Srinivas TR; Hemming AW; Soldevila-Pico C; Firpi RJ; Reed AI; Morelli GJ; Nelson DR; Abdelmalek MF Liver Transpl; 2006 May; 12(5):754-61. PubMed ID: 16528716 [TBL] [Abstract][Full Text] [Related]
14. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006 [TBL] [Abstract][Full Text] [Related]
15. Live donor liver transplantation in high MELD score recipients. Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705 [TBL] [Abstract][Full Text] [Related]
16. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767 [TBL] [Abstract][Full Text] [Related]
17. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality. Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574 [TBL] [Abstract][Full Text] [Related]